Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I can't even guess to be honest.
I'd hope to see somewhere around $3M, $60M/annual would come out to $5M a month, which I don't think is too far of a stretch.
Just need to see financials to say for sure.
Yup, I'm accumulating too. The assets alone make this so much more valuable.
I don't believe the revenue number, I think it's most likely a calculation based on the average revenue/employee multiplied by the amount of employees we have.
Would be nice, but I wouldn't bet on that amount.
no legit company goes dark and falls over a year behind on its financial disclosures
Just another guarantee/opinion that has yet to come to fruition, kind of like the price being sub penny within a month of going to the greys.
They are hiring people and signing deals. Thank you for finally acknowledging the legitimacy of the company.
Currently there is a disconnect between the stock and the company. The financials are the link to get us back up and trading.
I, along with many other forward thinkers can connect the dots, and we're betting on CareClix's future.
The 5 day average volume is 50,435 (up from 30k a week ago)
The 15 day average volume is 31,527 (up from 21k a week ago)
The 30 day average volume is 30,983 (up from 27k a week ago)
All of those average volumes are actually higher than the prior week. Does more volume mean less interest or more interest?
Dead stocks get 0 volume, don't file anything with the SEC, and definitely don't see increased in volume across multiple averages.
Additionally, dead companies don't hire, don't sign new deals and don't continue to grow.
With that definition, SOLI is not a dead company, nor is it a dead stock.
Legit companies don't sign deals with cities and government agencies, nor do they continue to hire during a pandemic when alot of companies are furloughing.
For a stock that supposedly has no eyes on it, there sure is alot of misinformation being spread, dont ya think?
What fake pump news?
Have you read the filings?
Bring it on! The category is showing great growth per the recent PR.
Even a link will do.
Trying to pick up more at .20.
Agreed, would love a copy of the lawsuit, or at least who it's against.
Sure doesn't make sense, good example of a sleeper stock :)
Just because financials haven't been posted in a year doesn't invalidate the fact CareClix Inc is owned by SOLI.
From there you can see everything that connects to CareClix inc. Go look at EdF's post to see what CareClix has been up to the last 6 months.
I really don't care if you want to buy or sell, if you are bullish or bearish, but provide facts.
People who DD will see exactly what they own. Facts will win out.
We aren't splitting hairs. You're claiming CareClix isn't a telemedicine company despite facts proving they generate telemedicine revenue as well as software that allows doctors to provide virtual visits.
All I smell is more revenue :p
This unfortunate event with the unrestricted shares is just a short term hurdle. No reason we shouldn't be trading at a much higher multiple!
Wish I had more funds, it's just so damn expensive to buy a chunk at these prices for us little guys :p
I need a lot higher lol, but good start.
$15k+ a day for the last handful of days, of a so called dead, grey sheet scam with no one watching. Unfortunately, if $15k is traded, that would mean it's not dead and folks are indeed buying/watching. Facts Elvis.
ELVIS, geez man, read lol.
Yes the SAAS is set up so that third party individuals, like say your doctor, can use the CareClix software and connect with you (the doctor's patient). In this case YOU ARE NOT utilizing CareClix's contracted doctors, hence why this stream of revenue is just software related.
The telemedicine side is just like all the other telehealth players out there, and I've proven that point over and over with the way CareClix Network is similarly set up to Teladoc's doctor network:
...using the CareClix contracted medical doctors...
Customers are charged for their service and then CareClix Inc turns around to pay the network of doctors for their service. This removes all liability from CareClix Inc and onto the CareClix Network.
The CareClix Network is it's own business structure. It receives revenue for it's services and then pays the doctors. So your statement is like saying CareClix network isn't a telemedicine business because they pay someone else (the doctors) to do the work.
This is like any major business you can think of. Best Buy charges its customers for DVDs. Those DVDs have a cost associated with them. Your argument is like stating, Best Buy isn't in the DVD business because they don't make their own DVDs. Well duh they don't, they make the money on the difference between the cost and what they charge. If you want a software example, it's like saying Apple isn't in the music business because iTunes isn't actually their music. They pay the artists while getting paid by people who buy songs. Just like how Teladoc makes money on the difference between the money they bill users, and the offsetting cost for the doctor's time/expertise.
Too many unknowns.
No idea how many more shares are left to be sold, no idea if the seller of the shares is happy with what they got out and will hold the rest, maybe company reached out to them, etc.
I would love for bottom to be in and we start trending back higher. If that is not the case, I will continue to buy, because I think at this price we're undervalued and I look forward to seeing next Qs revenues, due in about a month I believe.
Again, you want to see a financial mess, go look at the competitors in the space, losing hundreds of millions of dollars each quarter, and yet they keep getting fresh capital.
Telehealth is a hot sector right now, and if someone wants to base their entire opinion on 1 set of financials without checking to see what the company is doing behind the scenes (hiring many people, signing new deals, teaming up with large cities to promote CareClix) and without checking what competitors are doing, then that's their loss.
Just read between the lines; you won't get anywhere just "reading".
If it had no eyes then we wouldn't have seen 50k shares traded each of the last 4 days. Fact.
Elvis, you claim you read the Q and the K, and you say how bad it is, yet you can't find where it says telehealth services? Come on man, I gave you the exact page numbers too.
You want to see bad? Go look at AmWell's financials, and despite losing $150M they trade at almost $7Billion market cap. Never seen a hot future sector before?
Chart reminds me of IBGR when it was sub 002. Every pop got sold on very low volume. Then it steadily rose from .001 to .038.
CRTL I'll get everything I can if they want to bring it back to .01s. I can see this one moving over .10 at some point.
It will be nice to get rid of these sellers once and for all.
The positive is I have to assume that many folks buying, aren't flipping. There is no interest on this board except for us long term holders, so it should still be quick on the way back up.
The Company and its subsidiaries currently maintain three separate lines of revenue; revenue from sales of product by Clinical and Herbal Innovations; revenues from use of the recently acquired CareClix software by third parties (Software as a Service or SaaS); and revenues from patient consultations through the CareClix telemedicine system. The revenues from these three lines of business are recognized as follows:
It's a pretty hard fact to miss if you've looked at the financials ever.
Page F-9
SaaS: The CareClix software system is used by certain third-party customers to service their telemedicine clients under written service agreements with CareClix, Inc. Those clients generally pay a co-pay at the time of service, in most cases by credit card, and those co-pay fees are transmitted to CareClix, Inc. through STRIPE, a card processing service, as part of the third-party service agreement.
Telemedicine Revenues: Other customers of CareClix use the CareClix telemedicine platform directly to service their clients or members and the CareClix software maintains the record of the number of consultations and other work performed for the customer’s clients, using the CareClix contracted medical doctors, and CareClix bills the customer monthly for all services provided during the month, in accordance with the written agreement between CareClix and the customer.
If you look at the price alone, yes pump and dump looks like a good description, but the volume doesn't show big volume, just lack of interest in my opinion.
We're a "boring" stock for OTC traders now. Fundamentally we're growing nicely, and we're valued much more than where we are now, but that's not good enough for this exchange. We belong on a real exchange where analysts and companies evaluate a company on earnings, not the next "catalyst" to move the stock.
I disagree and the last financials, yes elvis we know how late they are, also provides revenue from telehealth which disputes your claim with facts, again.
Saw that.
I love etrade, along with all the other brokers out there, feel the need to restrict our trading.
What they should do is just put up a warning when you enter a buy and then leave us alone. I know some folks don't understand the risks of buying/selling OTC stocks, but the rest of us do.
CareClix is a leading virtual healthcare solution company that provides software applications coupled with medical services enabling patients to receive care anytime at anyplace. CareClix’s suite of services is revolutionizing the way hospitals, doctors, and clinical care providers can interact with an increasing number of patients. CareClix Inc. is a wholly-owned subsidiary of CareClix Holding Inc. (SOLI)-OTC
Today it's going up, 4%. Decent volume too :)
I find that odd too. Crazy volume the last few weeks, O/S still intact. Idk what to think.
I recommend everyone reach out to KAVL's IR demanding answers related to the share price and increase in unrestricted shares.
I've been on them almost every other day, so maybe if they heard it from more than me we'd get somewhere.
Agreed, we all are.
I think this range and lower are steals of a price. Assuming we do the same revenue the next 2 quarters, with no growth, which seems unlikely due to increased distributors and additional product, then we would currently be trading at 10x P/E.
With the growth we're seeing, and the ability to toss in new products into our distribution network, I think we can all agree something greater than 10x is warranted.